FOLH1 and nonpapillary renal cell carcinoma: When compared to conventional imaging and 18F-FDG, PSMA radioligand PET/CT showed overall better performance in nine of the included studies which analysed ccRCC patients in all the examined clinical contexts [48,49,53,54,56,57,58,61,63].